Key points are not available for this paper at this time.
This study uses data from the US nationwide electronic health record–based Epic Cosmos Dataset to examine prescriptions for semaglutide and tirzepatide, focusing on differences across race, ethnicity, social vulnerability, and urbanicity and assess the need for strategies to promote equitable access to these therapies.
Kim et al. (Tue,) studied this question.